Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BRAINSTORM CELL THERAPEUTICS INC. | EVP, Chief Operating Officer | Common Stock | 52K | $11.9K | $0.23 | Jan 1, 2025 | Direct |
BRAINSTORM CELL THERAPEUTICS INC. | EVP, Chief Operating Officer | Stock Option (Right to Buy) | 60K | Jun 24, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BCLI | BRAINSTORM CELL THERAPEUTICS INC. | Jan 1, 2025 | 1 | $0 | 4 | Jan 3, 2025 | EVP, Chief Operating Officer |
BCLI | BRAINSTORM CELL THERAPEUTICS INC. | Jun 24, 2024 | 2 | $0 | 4 | Jun 25, 2024 | EVP, Chief Operating Officer |
BCLI | BRAINSTORM CELL THERAPEUTICS INC. | Jun 24, 2024 | 0 | $0 | 3 | Jun 25, 2024 | EVP, Chief Operating Officer |